GlassScriptPhysician profile
Dustin K Smyth
NPI 1457705568
$1,178.20
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $722 · 2020: $174 · 2021: $23.29 · 2022: $153 · 2023: $107.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $107.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $107.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $332.88 | 2019-2023 | Ultomiris |
| Ucb, INC. | $284.03 | 2019-2020 | |
| Allergan, INC. | $124.99 | 2019 | |
| Adamas Pharmaceuticals, INC. | $120.35 | 2020 | |
| Acorda Therapeutics, INC | $68.75 | 2019 | |
| Genentech USA, INC. | $56.10 | 2019 | |
| Emd Serono, INC. | $41.37 | 2019 | |
| Csl Behring | $38.18 | 2019-2020 | |
| Abbvie INC. | $29.02 | 2022 | |
| Kyowa Kirin, INC. | $23.29 | 2021 | |
| Jazz Pharmaceuticals INC. | $20.36 | 2022 | |
| Sk Life Science, INC. | $20.26 | 2022 | |
| Amgen INC. | $18.62 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Smyth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.